Relapsed or refractory classical Hodgkin lymphoma - with Dr Robin Gasiorowski. EHA 2020

(18:46)

What are some of the FDA approved treatments for relapsed or refractory AML?

(8:45)

Relapsed or Refractory Polycythemia Vera

(5:27)

The devastating effects of relapsed or refractory AML

(3:)

How Is Relapsed or Refractory Myeloma Managed?

(7:2)

What Relapsed Or Refractory Means In Multiple Myeloma

(53)

Defining Relapsed and Refractory Myeloma; what's the difference?

(4:41)

Relapsed or Refractory EGFR+ NSCLC

(4:49)

A study of pembrolizumab maintenance as an alternative to autoSCT in R/R Hodgkin lymphoma

(3:20)

Combination Therapies for Relapsed or Refractory AML

(59:54)

How I treat relapsed or refractory ALL

(17:39)

What are the alternative treatment options for relapsed or elderly AML patients?

(1:14)

How Is Relapsed or Transformed Follicular Lymphoma Treated?

(5:2)

Phase I study shows nivolumab is safe and tolerable for relapsed or refractory Hodgkin lymphoma

(7:51)

Management of FL relapsed or progressed after frontline lenalidomide and rituximab

(1:38)

Immunotherapy Trial for Kids with Relapsed or Refractory Leukemias and Solid Tumors

(3:43)

FDA D.I.S.C.O.: A new drug approval for IDH1 positive relapsed or refractory Acute Myeloid Leukemia

(6:31)

Optimizing CAR T-Cell Therapy in Relapsed/Refractory ALL

(5:38)

What does a physician need to consider when treating relapsed or refractory myeloma?

(4:54)

Relapsed and Refractory Hodgkin Lymphoma

(4:24)